LCM
TCRT icon

Landscape Capital Management’s Alaunos Therapeutics TCRT Stock Holding History

Landscape Capital Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-649
Closed -$605K – 557
2017
Q2 		$605K Sell
649
-270
-29% -$265K 0.07% 184
2017
Q1 		$834K Buy
919
+649
+240% +$604K 0.08% 204
2016
Q4 		$217K Buy
+270
New +$243K 0.03% 468
2016
Q3 		– Sell
-1,759
Closed -$1.45M – 580
2016
Q2 		$1.45M Sell
1,759
-1,962
-53% -$2.14M 0.19% 129
2016
Q1 		$4.14M Buy
3,721
+3,053
+457% +$3.12M 0.5% 35
2015
Q4 		$833K Buy
668
+268
+67% +$443K 0.1% 257
2015
Q3 		$541K Sell
400
-35
-8% -$57.8K 0.07% 299
2015
Q2 		$782K Buy
435
+229
+111% +$355K 0.13% 186
2015
Q1 		$333K Buy
+206
New +$305K 0.09% 322

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Landscape Capital Management's TCRT Position: Q3 2017 in Review

Landscape Capital Management sold out of Alaunos Therapeutics (TCRT) in Q3 2017, closing a stake of 649 shares — an estimated $605K sold.

Landscape Capital Management first reported a position in TCRT in Q1 2015 and held it in 9 quarters. The position peaked at $4.14M in Q1 2016. 122 funds tracked by Wall St. Rank hold TCRT as of Q3 2017.

  • Landscape Capital Management reported no remaining Alaunos Therapeutics position as of Q3 2017 after selling out during the quarter.
  • Landscape Capital Management sold 649 Alaunos Therapeutics shares in Q3 2017, an estimated $605K.
  • Landscape Capital Management first reported a position in Alaunos Therapeutics in Q1 2015 and held it in 9 quarters.
  • Landscape Capital Management's Alaunos Therapeutics position peaked at $4.14M in Q1 2016.
  • 122 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2017.

Based on Landscape Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.